Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo


We manufacture, supply and distribute commercial formulations for oral solids from our Sellersville, Morpeth and Pithampur facilities. Apart from OSDs we also provide liquids, creams and ointments from our Sellersville facility and sterile injectables from our Lexington site. We are a trusted manufacturing partner to leading biotech, small and virtual pharmaceutical companies as well as mid-size and big pharmaceutical companies. Our scalability is defined from pilot level to commercial level to serve customers at every stage of drug lifecycle from manufacturing perspective. We leverage our global network of manufacturing sites and are successful in supplying commercial formulations to the US, Europe, Japan and Asia Pacific markets.

Cytotoxic and Potent Compounds

Piramal’s facilities and skilled team of experts can help you safely and efficiently turn your high-potency project into a success. We routinely specialize in formulating highly toxic compounds, suchas cytotoxics, hormones, potent substances, controlled substances and steroids into safe and effective oral solids, liquid or lyophilized drug products.

We employ state-of-the-art mobile isolator technology in our manufacturing facility to provide a physical barrier that protects our staff from toxic substances and encloses your product in a Class A Environment. Similar fixed isolators are used in our development labs to mimic manufacturing operations and enable formulation and analytical development on toxic substances. Through the use of these high containment “glove boxes,” our scientists create and maintain a controlled sterile envelope that enables us to process potent drug classes including cytotoxins, steroids, hormones, and acutely toxic substances.

Additionally, we can assist our clients in evaluating the hazards associated with their compounds through our new product assessment program to determine an Occupational Exposure Limit (OEL). Our operating systems require that all direct product contact equipment is either dedicated or disposable in order to provide robust protection against cross-contamination.

With a client base that includes large and small pharma, biotech’s, animal health, academic and government institutions, Lexington has expertise to support manufacturing from pre-clinical to routine commercial manufacturing, while our Sellersville facility has expertise in manufacturing of potent and controlled substances.

From simple solutions to the most complex formulations, we have successfully supported oral solids,liquid and lyophilized drug candidates for our customers.